Ginkgo biloba/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on total leukocyte count
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The white blood cell count did not change either in the GKB or in the placebo group after 90 days.”
Quoted verbatim from The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial.. - Study
- RCT
- Participants
- 47
- Duration
- 3 months
- Dose
- 120 mg once daily for 90 days, added to ongoing metformin
- Population
- Adults aged 25 to 65 with type 2 diabetes uncontrolled on metformin, recruited in Sulaimani, Iraq; both arms continued their usual metformin dose throughout.
The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial.2018PMID:29670330Permalink
Keep reading
- Everything the graph holds on Ginkgo biloba
- Every compound studied against Total leukocyte count
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M10EA7NYBQYV6B4NG7YBPSPR